Skip to content

Evaluation of the Method and Duration of Urinary Diversion in the Management of Distal Penile Hypospadias Following Surgical Repair.

Evaluation of the Method and Duration of Urinary Diversion in the Management of Distal Penile Hypospadias Following Surgical Repair.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07421271
Enrollment
86
Registered
2026-02-19
Start date
2025-04-10
Completion date
2025-12-12
Last updated
2026-02-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypospadias, Urinary Diversion

Brief summary

This study aims to conduct a head-to-head comparison to determine the optimal method and duration of urinary diversion following distal penile hypospadias repair. Specifically, it will evaluate whether urethral diversion alone or a combination of urethral and suprapubic diversions provides better outcomes, and whether a postoperative duration of one week or two weeks is more effective.

Interventions

PROCEDUREApplication of urethral catheter alone for 1 week.

Application of urethral catheter alone for 1 week.

PROCEDUREApplication of urethral catheter alone for 2 weeks.

Application of urethral catheter alone for 2 weeks.

PROCEDUREApplication of urethral stent and suprapubic catheter for 1 week

Application of urethral stent and suprapubic catheter for 1 week

PROCEDUREApplication of urethral stent and suprapubic catheter for 2 weeks

Application of urethral stent and suprapubic catheter for 2 weeks

Sponsors

Ain Shams University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
MALE
Age
6 Months to 18 Years
Healthy volunteers
No

Inclusion criteria

* Patients with Distal Hypospadias (Glanular, Coronal, Subcoronal) * Patients have Adequate ventral penile skin mobility

Exclusion criteria

* Patients with Crippled hypospadias. * Patients with Proximal hypospadias. * Patients with Hypoplastic urethra. * Patients with Neurogenic bladder

Design outcomes

Primary

MeasureTime frame
Decreased rate of fistula occurrence1 month

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 20, 2026